Clinical Trial Update: Vismodegib in Treating Patients With Advanced Chondrosarcomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vismodegib for advanced chondrosarcomas has posted results in 2019 and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Chondrosarcoma
• Chondrosarcoma
• Clear Cell Chondrosarcoma
• Dedifferentiated Chondrosarcoma
• Mesenchymal Chondrosarcoma
• Unresectable Primary Central Chondrosarcoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2019-11-15